SAN MARINO, Calif., Aug. 7 /PRNewswire-FirstCall/ -- Biotechnology company Viral Genetics has formed a wholly owned subsidiary called MetaCytoLytics, Inc. This company was created to advance a technology developed by University of Colorado Professor M. Karen Newell called "metabolic disruption technology" (MDT), which focuses on blocking a tumor cell's ability to generate energy from glucose or from fatty acids. That process has been found in animal studies to not only directly cause cancer cells to die but also to synergize with existing treatments such as chemotherapy and radiation therapy to further limit the growth of tumor cells. Dr. Richard J. Trauger, Ph. D., will be chief executive officer of the new company. He will focus on bringing this concept forward into clinic trials and expanding the indications provided by the technology platform.

Port Jefferson, New York, August 4, 2009 – Wide World of Stocks™, a new 30-minute taped television and website program that seeks to showcase microcap stocks, will feature Location Based Technologies, Inc., a Nevada corporation (OTCBB:LBAS) in its second episode.

Port Jefferson, New York, August 4, 2009 – Wide World of Stocks™, a new 30-minute taped television and website program that seeks to showcase microcap stocks, will feature Location Based Technologies, Inc., a Nevada corporation (OTCBB:LBAS) in its second episode.